Generating iPSCs: translating cell reprogramming science into scalable and robust biomanufacturing strategies.
Cell Stem Cell
; 16(1): 13-7, 2015 Jan 08.
Article
en En
| MEDLINE
| ID: mdl-25575079
ABSTRACT
Induced pluripotent stem cells (iPSCs) have the potential to transform drug discovery and healthcare in the 21(st) century. However, successful commercialization will require standardized manufacturing platforms. Here we highlight the need to define standardized practices for iPSC generation and processing and discuss current challenges to the robust manufacture of iPSC products.
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Técnicas de Cultivo de Célula
/
Reprogramación Celular
/
Células Madre Pluripotentes Inducidas
Límite:
Animals
/
Humans
Idioma:
En
Año:
2015
Tipo del documento:
Article